MHMan Hagiyama

Man Hagiyama

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Man Hagiyama has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • PS 07-18 HEART-BOUND ADIPONECTIN, NOT SERUM ADIPONECTIN, CORRELATES WITH CARDIAC HYPERTROPHY IN STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS

    by Takao Inoue, Kumiko Takemori, Nobuyuki Muzuguchi, Masatomo Kimura, Takaaki Chikugo, Man Hagiyama, Azusa Yoneshige, Tatsufumi Mori, Takashi Kometani, Tatsuki Itoh, et al.

    The relationship between serum adiponectin concentration and hypertension or cardiac hypertrophy is still controversial. We have previously proposed that tissue-bound adiponectin possibly plays an important role against metabolic syndrome. In this study, we investigated the relationship between heart-bound adiponectin and hypertension or cardiac hypertrophy, compared with serum adiponectin in hypertensive rats. Six-, 12-, and 20-week-old Wistar-Kyoto rats (WKY); 2 subspecies (strains C and B2, characterized by having lower and higher blood pressure, respectively) of spontaneously hypertensive rats (SHR); and stroke-prone SHR (SHRSP) were used. Blood pressure, heart/body ratio, serum adiponectin, and heart-bound adiponectin were measured. Histopathological analyses of the heart were also carried out. The heart/body ratio strongly correlated with blood pressure in 12- and 20-week-old rats, as expected. Serum adiponectin concentration, however, was positively correlated with blood pressure in 12- and 20-week-old rats, and the heart/body ratio and heart muscle cross-sectional area in 20-week-old rats, indicating that there is no relationship between serum adiponectin and blood pressure or cardiac hypertrophy in these rats. In contrast, heart-bound adiponectin in SHRSP was significantly decreased than that in other species of all ages. This results from a decrease in T-cadherin expression, which induces adiponectin binding to tissues. Heart-bound adiponectin inversely correlated with the heart muscle cross-sectional area, but not with blood pressure, indicating that heart-bound adiponectin is more closely related with cardiac hypertrophy than serum adiponectin concentration in these rats. Some researches have reported that serum adiponectin concentration is a useful parameter for evaluating the health condition. Some patients, however, showed hypertension and cardiac hypertrophy despite having high adiponectin concentrations in blood. Our results suggest the possibility that such patients would have decreased heart-bound adiponectin mediated by T-cadherin, and a high adiponectin concentration in blood.

  • Estimating cell adhesion strength

    by Yoichiroh Hosokawa, Takanori Iino, Man Hagiyama, Akihiko Ito

    Tracking the bending movement of an atomic force microscope cantilever arm helps quantify the local impulsive force required to shift one cell relative to another.

  • Adhesion molecule CADM1 contributes to gap junctional communication among pancreatic islet α-cells and prevents their excessive secretion of glucagon

    by Akihiko Ito, Naoki Ichiyanagi, Yuki Ikeda, Man Hagiyama, Takao Inoue, Keiko B. Kimura, Minami A. Sakurai, Kazuyuki Hamaguchi, Yoshinori Murakami

    Cell adhesion molecule-1 (CADM1) is a recently identified adhesion molecule of pancreatic islet α-cells that mediates nerve–α-cell interactions via trans-homophilic binding and serves anatomical units for the autonomic control of glucagon secretion. CADM1 also mediates attachment between adjacent α-cells. Since gap junctional intercellular communication (GJIC) among islet cells is essential for islet hormone secretion, we examined whether CADM1 promotes GJIC among α-cells and subsequently participates in glucagon secretion regulation. Dye transfer assays using αTC6 mouse α-cells, which endogenously express CADM1, supported this possibility; efficient cell-to-cell spread of gap junction-permeable dye was detected in clusters of αTC6 cells transfected with nonspecific, but not with CADM1-targeting, siRNA. Immunocytochemical analysis of connexin 36, a major component of the gap junction among αTC6 cells, revealed that it was localized exclusively to the cell membrane in CADM1-non-targeted αTC6 cells, but diffusely to the cytoplasm in CADM1-targeted cells. Next, we incubated CADM1-targeted and non-targeted αTC6 cells in a medium containing 1 mM glucose and 200 mM arginine for 30 min to induce glucagon secretion, and found that the targeted cells secreted three times more glucagon than did the non-targeted. We conducted similar experiments using pancreatic islets that were freshly isolated from wild-type and CADM1-knockout mice, and expressed glucagon secretion as ratios relative to baseline values. The increase in ratio was larger in CADM1-knockout islets than in wild-type islets. These results suggest that CADM1 may serve as a volume limiter of glucagon secretion by sustaining α-cell attachment necessary for efficient GJIC.